Showing results (491-500 of 545) with videos related to

Sort By:
Pageof 55
The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.
JAMA Network Open|June 12, 2025
Pediatric Intensive Care Nurse Staffing Measures and Patient Outcomes During the COVID-19 PandemicWarren Michael Taylor, Jonathan Pelletier, Julia A Heneghan, et al.
Electrophoresis|March 12, 2026
Improvement of Peak Integration in Capillary Electrophoresis: Reference Data Set No. 1Marlon Krompholz, Timothy Blanc, Huixin Lu, et al.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2012
Antibodies and IL-3 support helminth-induced basophil expansionTina Herbst, Julia Esser, Moira Prati, et al.
Behaviour Research and Therapy|December 16, 2023
Exposure and response prevention versus stress management training for adults and adolescents with obsessive compulsive disorder: A randomized clinical trialJoseph A Himle, Andrew Grogan-Kaylor, Matthew A Hiller, et al.
American Journal of Epidemiology|April 5, 2007
Using probabilistic corrections to account for abstractor agreement in medical record reviewsTimothy L Lash, Matthew P Fox, Soe Soe Thwin, et al.
The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Trials|November 28, 2013
A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trialChristopher N Hurt, Kirsty Roberts, Trevor K Rogers, et al.
Health Technology Assessment (Winchester, England)|October 23, 2015
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)Simon I Noble, Annmarie Nelson, David Fitzmaurice, et al.
Pageof 55